Back to Search
Start Over
[Biological treatment of psoriasis and psoriatic arthritis].
- Source :
-
Ugeskrift for laeger [Ugeskr Laeger] 2008 Jun 09; Vol. 170 (24), pp. 2148-50. - Publication Year :
- 2008
-
Abstract
- Psoriasis is an immune-mediated inflammatory skin disease which may be associated with psoriatic arthritis. Biological therapy is indicated in patients who do not respond to, or are intolerant to, or have contraindication against traditional therapy. TNFalpha antagonists are used for both skin and joint disease, while efalizumab, which targets T lymphocytes, is only indicated for the skin disease. Registration of the treated patients in quality databases is an essential instrument in the surveillance of beneficial and adverse events during biological therapy.
- Subjects :
- Adalimumab
Anti-Inflammatory Agents adverse effects
Antibodies, Monoclonal adverse effects
Antibodies, Monoclonal, Humanized
Arthritis, Psoriatic immunology
Etanercept
Humans
Immunoglobulin G adverse effects
Immunoglobulin G therapeutic use
Immunologic Factors adverse effects
Infliximab
Psoriasis immunology
Receptors, Tumor Necrosis Factor therapeutic use
Treatment Outcome
Anti-Inflammatory Agents therapeutic use
Antibodies, Monoclonal therapeutic use
Arthritis, Psoriatic drug therapy
Immunologic Factors therapeutic use
Psoriasis drug therapy
Subjects
Details
- Language :
- Danish
- ISSN :
- 1603-6824
- Volume :
- 170
- Issue :
- 24
- Database :
- MEDLINE
- Journal :
- Ugeskrift for laeger
- Publication Type :
- Academic Journal
- Accession number :
- 18565300